Leonard Braden Michael

10% OwnerAclaris Therapeutics, Inc. (ACRS) · full profile →Form 4 · filed Apr 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2026Sell(S)300K$4.53$1.4M13.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001373604-26-000034) within minutes of acceptance. Every field above traces to the original document. Verify it directly: